Professional Documents
Culture Documents
Poloxamers are block-copolymers consisting of Polyoxyethylene-(POE-) and Polyoxypropylene-(POP-) units Chemical composition: CH HO CH 2 CH 2 O a CH 2 CH 3 O b CH 2 CH 2 O a H
POE-unit
Pharmacopoeial name Poloxamer 188 Poloxamer 407 a = ca. 79 a = ca. 98
POP-unit
POE-unit
Trade Name
b = ca. 28 b = ca. 57
Actives
Excipients
Contract Manufacturing
Value Added
Lutrol F Grades
Also Available
n n n
n n n
Actives
Excipients
Contract Manufacturing
Value Added
Poloxamers Characteristics
polyoxyethylene(EO-) units
AND
n
polyoxypropylene(PO-) units
Actives
Excipients
Contract Manufacturing
Value Added
Poloxamer Grid
4000
401
402
403
407
Liquid
331 333
Paste
334 335
Solid
338
272
278
221
224
225
227
228
202
205
207
181
182
183
184
185
188
122 101
123
10
20
30
40
50
60
70
80
Actives
Excipients
Contract Manufacturing
Value Added
Lutrol Grid
L121
L122
P123
F127
Liquid
L101 P103
Paste
P104 P105
Solid
F108
Molecular weight
L92
F98
P84
P85
F87
F88
L72
P75
F77
L62
L63
L64
P65
F68
L42
L43
10
20
30
40
50
60
70
80
EO-part (Wt.%) 8 x 10 = 80 7 x 10 = 70
Lutrol F 12 7
12 x 1000 = 12000
Actives
Excipients
Contract Manufacturing
Value Added
100
1.000
molecular weight
10.000
100.000
Mw 8,600 9,000
Actives n
Mn 7,600 8,100
Excipients n
100
1.000
molecular weight
10.000
100.000
Mw 13,400 13,500
Mn 9300 9500
Actives
Excipients
Contract Manufacturing
Value Added
The molecular weight distribution is dependant on side reactions, which occur during propylene oxide polymerization. During formation of POP block, a fraction of propylene oxide may be converted to allyl alcohol which will futher react with PO and EO producing a polymeric material about half the molecular weight of the main product. This segment constitute the unsaturation part of Lutrol F127 ( 0.048 meq/gm). In the USP, the average molecular weight is 9840 to 14600.
Actives
Excipients
Contract Manufacturing
Value Added
Formation of Unsaturation
H H H
O
KOH
H H O
H
n+1
CH 2 CHO CH 3
n
CH 2 CHO CH 3
CH 2 CH 2 O
Contract Manufacturing
Value Added
CH3 HO-(CH2-CH2-O)x-(CH2-CH-O)y-(CH2-CH2-O)x-H where x = approx. 98 and y = approx. 57 Poloxamer is terminated with hydroxyl group therefore further reactions will not occur (will not self polymerize)
n Actives n Excipients n Contract Manufacturing n Value Added
Principle of Micellization
surfactant m o lecule
Polar Solvent
Actives
Excipients
Contract Manufacturing
Value Added
As a Solubilizer
Solubilization capacity of a poloxamer is believed to be dictated by the hydrophobic portion One theory is that in water, the poloxamer molecules arrange themselves in an umbrella like configuration:
POP Group
POE Group
Actives
Excipients
Contract Manufacturing
Value Added
Actives
Excipients
Contract Manufacturing
Value Added
Solubilizer Solubilizer
Gels Gels
Actives
Excipients
Contract Manufacturing
Value Added
Prill
n n
Microprill
n n n
*Development Product
Actives
Excipients
Contract Manufacturing
Value Added
Advantages of Microprilling
n n n n n n n
Average particle size 50 micron Stronger solubilization activities Controlled dissolution rate Reduction of die-wall friction Achievement of homogeneous blend Elimination of dose dumping Effective water soluble lubricant
Actives
Excipients
Contract Manufacturing
Value Added
Microprill meets the following specification n Max. 10% retain in 106 micron (#140 Screen) n Max. 50% retain on 53 micron (#270 Screen)
n
Using Alpine Air Jet Sieve Analysis Chemical Specification is identical to regular prill and complies with USP/NF specification
Actives
Excipients
Contract Manufacturing
Value Added
SEM
Actives
Excipients
Contract Manufacturing
Value Added
Lutrol 68 Microprill
Particle Size Distribution
10 9.5 9 8.5 8 7.5 7 6.5 6 5.5 5 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0 0.1 100 90 80 70 60 50 40 30 20 10 1 10 Particle Size (m) 100 1000 0 3000
Actives
Excipients
Contract Manufacturing
Value Added
Surface Area
Sample
Not Possible
0.18
Actives
Excipients
Contract Manufacturing
Value Added
Material Lutrol F68 Prill Lot # WPDX-577B Lutrol 68 Microprill Lot # WPNZ-664BMP
0.52
0.78
1.10
Actives
Excipients
Contract Manufacturing
Value Added
Melt Viscosity
Equipment :
Brookfield RVT-DVII with Thermoseal & Temperature Controller Temperature Set and Maintained at 80C, Spindle #27
Actives
Excipients
Contract Manufacturing
Value Added
Sample Name
Mn
Mw
MP
Polydispersity
% Area
Area
Retention Time
Project #
8611
9332
9956
1.083755
100.0
2861502
18.411
2S011
8809
9656
10288
1.096190
100.0
3711903
18.356
2S011
15.00
16.00
17.00
18.00
19.00
20.00
21.00
24.00
25.00
26.00
27.00
28.00
29.00
30.00
Actives
Excipients
Contract Manufacturing
Value Added
To 48.9 50.1
Tp 51.6 52.4
H 121.7 121.7
To = Extrapoloated onset of melting endotherm in C Tp = Peak of melting endotherm in C H = Enthalpy of melting endotherm in joules/gram
Actives
Excipients
Contract Manufacturing
Value Added
DSC
DSC
50.09C 134.3J/g
-2
53.56C
-4
-6 -60
Exo Up
Lutrol 68 Microprill
-40 -20 0 20 40 60 80 100
Universal V3.8B TA Instruments
Temperature (C)
DSC
2
2nd heat
2C/min
49.64C 119.8J/g
-1
52.32C
Exo Up
-2 0
10
20
30
40
Temperature (C)
50
60
70
80
90
100
Actives
Excipients
Contract Manufacturing
Value Added
X-Ray Diffraction
14000
13000
12000
11000
10000
9000
5000
4000
3000
2000
1000
0 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
2-Theta - Scale -2 - - - -.
Actives
Excipients
Contract Manufacturing
Value Added
pharma SOLUTIONS
Formulations
Material
Ibuprofen Carbamazepine Ltrol micro Di-calcium Phosphate Calcium Carbonate 90A Kollidon CL Aerosil 200 Magnesium Stearate
Formulation A (%) 5.0 5.0, 25.0, 50.0 79.0, 69.0, 59.0, 34.0 10.0 0.5 0.5
Formulation B (%) 5.0 25.0, 50.0 59.0, 34.0 10.0 0.5 0.5
Actives
Excipients
Contract Manufacturing
Value Added
% Drug Release
Time (Hrs)
100
% Drug Release
80
60
40
20
0 0 1 2 3 4 5
Time (hrs)
100
% Drug Release
80
60
40
0 0 1 2 3 4 5
Time (hrs)
The thermoreversible gelling effect, along with the smaller particle size of Lutrol 127 micro gave a controlled release profile
Actives
Excipients
Contract Manufacturing
Value Added
Dissolution studies with tablets via direct compression and solid dispersion were evaluated Regular prill used for Solid dispersion and Microprill for Direct Compression Tablets compressed using 9.5mm round flat face bevel edge tooling Target weight 400mg, target hardness 4-5Kp Using Carbamazepine as a model drug, due to its limited solubility in water dissolution studies were carried out using a co-solvent of water and ethanol (70:30)
Actives
Excipients
Contract Manufacturing
Value Added
% Drug Release
60 50 40 30 20 10
0 0 1 2 3 4 5
Time (hrs)
% Drug Release
60 50 40 30 20 10 0 0 1 2 3 4 5
Time (Hrs)
% Drug Release
60 50 40 30 20 10 0 0 1 2 3 4 5
Time (Hrs)
Dissolution Media 70:30 Ethanol:Water HPLC Column 5m CN 250mm x 4.6mm
n Actives n Excipients n
100
% Drug Release
80
60
40
20
Control
0 0 1 2 3 4 5
Time (hrs)
Both Lutrol 68 micro and Lutrol 127 micro improved the dissolution of Carbamazepine
Actives
Excipients
Contract Manufacturing
Value Added
pharma SOLUTIONS
Made Carbamazepine tablets using different granulation techniques: n Direct Compression n Wet Granulation n Melt Granulation Two ratios evaluated: 1:3 and 1:5 (Drug: Poloxamer) Microprill was used only in Direct Compression Tablets compressed at 400mg, target hardness 5-7Kp
n n
Actives
Excipients
Contract Manufacturing
Value Added
100
% Drug Release
80
60
Direct Compression
40
Melt Granulation
20
Time (Mins)
n Actives n Excipients n Contract Manufacturing n Value Added
% Drug Release
Time (Hrs)
n Actives n Excipients n Contract Manufacturing n Value Added
100
% Drug Release
80
60
Direct Compression
40
Melt Granulation
20
Time (Hrs)
n Actives n Excipients n Contract Manufacturing n Value Added
100
% Drug Release
80
60
40
20
Time (Hrs)
n n n n
Actives
Excipients
Contract Manufacturing
Value Added
Comparing 1:5 and 1:3 ratio Lutrol 127 direct compression tablet
90 80 70
% Drug Release
Time (Hrs)
n Actives n Excipients n Contract Manufacturing n Value Added
Conclusions
Use of poloxamers, regardless of granulation technique, improved the solubility of Carbamazepine. Higher levels of poloxamer create a greater binding effect, which has an impact on dissolution. Microprilled Poloxamers exhibit good blend homogeneity and eliminate the segregation problem during direct compression. The gelling characteristic of microprilled Poloxamer 407 can be used for controlled release or other drug delivery technology. Microprill poloxamer can be a good candidate as a water soluble lubricant for effervescent tablets.
Actives
Excipients
Contract Manufacturing
Value Added
Dissolution studies with capsules and tablets were evaluated Tablets compressed using 11mm round flat face bevel edge tooling Target weight 800mg, target hardness 4-5Kp Using Ibuprofen as a model drug dissolution studies were carried out at pH 4.5 (where Ibuprofen has limited solubility)
CRS 2005/ 32nd Symposium on Controlled Release of Bioactive Materials / 18.-22.06.2005 / Miami, Florida, U.S.A.
Actives
Excipients
Contract Manufacturing
Value Added